Emory Latino Diabetes Education Program (ELDEP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00793884|
Recruitment Status : Recruiting
First Posted : November 19, 2008
Last Update Posted : October 12, 2017
Latinos represent the largest minority group in the United States with a population of 35 million or 12.5%. National surveys indicate that the prevalence of type 2 diabetes is 1.9 times higher in Latinos than non-whites, and that approximately 24% percent of Latinos over the age of 45 years have diabetes. In Georgia, Latinos make up approximately 6.5% of the population. During 1990 and 2000, the prevalence of diabetes in Fulton and Dekalb counties, two of the most populated areas in Georgia and the Atlanta metropolitan area increased by 30%. Language and cultural barriers represent the two most important obstacles in educating and improving the care of Latino patients with diabetes. Less than 5% of physicians, 2% of nurses, and 2.5% of dentists in the US speak Spanish.
The Emory Latino Diabetes education program has been in existence since December 2005. Our program aims to deliver diabetes education in Spanish to the underserved Latino community in Metro Atlanta. Program participants attend an initial 2.5hr diabetes education class in Spanish. The class curriculum follows the American Association of Diabetes Educators (AADE) seven self-care behaviors: healthy eating, being active, monitoring, medication use, problem-solving and healthy coping. Participants are invited to return to a follow-up session within 6 months. Follow-sessions are held in the late afternoon. These sessions are discussion-based and include an activity such as salsa lessons and cooking demonstrations.
We would like to obtain IRB approval to analyze and publish that data we collect during our educational sessions. We would like to collect retrospective data from past participants in the program (for which we request a waiver of informed consent and HIPAA authorization), and we would like to consent current and future participants to use their data.
|Condition or disease|
Participants complete a questionnaire which assesses behaviors and social and demographic characteristics of the Latino community we serve. In order to track patients outcomes, at the beginning of each class we also measure A1C, blood pressure, weight, BMI and waist circumference.
Diabetes education classes and follow-up sessions are offered at Grady Memorial Hospital (Diabetes Clinic, International Medical Center), Grady North Dekalb Clinic (Chamblee), and North Fulton Regional Hospital.
|Study Type :||Observational|
|Estimated Enrollment :||800 participants|
|Official Title:||Emory Latino Diabetes Education Program|
|Study Start Date :||October 2008|
|Estimated Primary Completion Date :||December 2018|
|Estimated Study Completion Date :||December 2018|
Program participants attend an initial 2.5hr diabetes education class in Spanish. The class curriculum follows the American Association of Diabetes Educators (AADE) seven self-care behaviors: healthy eating, being active, monitoring, medication use, problem-solving and healthy coping. Participants are invited to return to a follow-up session within 6 months. Follow-sessions are held in the late afternoon. These sessions are discussion-based and include an activity such as salsa lessons and cooking demonstrations.
- To describe the social and demographic characteristics of the Latino population with diabetes mellitus in Georgia [ Time Frame: 3 years ]
- To examine barriers to health care among Latinos with Diabetes in the population we serve [ Time Frame: 3 years ]
- To determine differences in clinical outcomes (hemoglobin A1C, waist circumference, BMI, blood pressure) and diabetes self-management behaviors between initial and follow-up data [ Time Frame: 3 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00793884
|Contact: Britt Rotberg Wolfe, MS, RDN, LDfirstname.lastname@example.org|
|Contact: Guillermo Umpierrez, MDemail@example.com|
|United States, Georgia|
|Emory University School of Medicine||Recruiting|
|Atlanta, Georgia, United States, 30303|
|Contact: Britt Rotberg Wolfe, MS, RDN, LD 404-778-1697 firstname.lastname@example.org|
|Principal Investigator: Guillermo Umpierrez, MD|
|Study Director:||Britt Rotberg Wolfe, MS, RDN, LD||Emory University|
|Principal Investigator:||Guillermo Umpierrez, MD||Emory University|